What is topical steroid withdrawal?

What is topical steroid withdrawal?

Topical corticosteroid withdrawal refers to a rare adverse reaction relating to the use of a topical steroid after it has been discontinued. This reaction can occur after prolonged, inappropriate, and/or frequent use/abuse of moderate- to high-potency topical corticosteroids.

WHO classification topical corticosteroids?

As per the currently used potency-based classification system, topical corticosteroids can be divided into 7 classes, Class I superpotent (clobetasol propionate 0.05%, halobetasol propionate 0.05%, desoximetasone 0.25%), Class II: high-potent (betamethasone dipropionate 0.05% cream, halcinonide 0.1%), Class III: medium …

How do you treat steroid withdrawal?

In general, steroid withdrawal is treated by administering steroids to decrease or eliminate withdrawal symptoms, then gradually decreasing the amount of steroids given so the body can adjust to synthesizing steroids normally.

How do you treat steroid cream withdrawal?

Potential treatment options include:

  1. Slowly stopping the use of steroid creams. Gradually stopping topical steroid creams can help manage TSW.
  2. Immediately stopping the use of steroid creams.
  3. Taking oral corticosteroids.
  4. Using cold compresses.
  5. Taking antibiotics.
  6. Receiving a dupilumab injection.

What is the classification of corticosteroids?

Corticosteroids belong to two general drug classes: glucocorticoids and mineralocorticoids. Glucocorticoids mimic the actions of cortisol and are known for their anti-inflammatory effects and immunosuppressive properties.

What are the classes of corticosteroids?

Corticosteroid Classes

  • Class A: Hydrocortisone and tixocortol type. Cortisone.
  • Class B: Triamcinolone acetonide type. Triamcinolone acetonide.
  • Class C: Betamethasone type. Betamethasone.
  • Class D: Hydrocortisone – 17-butyrate and clobetasone-17-butyrate type. Hydrocortisone butyrate.
  • Prevention.

How is steroid induced dermatitis treated?

Treatment involves discontinuation of the offending topical steroid and administration of oral and/or topical antibiotics. Topical calcineurin antagonists should be considered as alternative or adjunctive therapies for patients who do not respond to traditional treatments.

author

Back to Top